Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 3 Multivariate analyses of risk factors for 30-day mortality in patients with CRE BSI

From: Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options

Risk factor

Multivariate analysis

OR (95% CI)

P value

Underlying hematological disease

0.337 (0.048–2.367)

0.274

Length of neutropenia (≥ 14 days)

3.731 (0.355-40)

0.272

Pitt bacteremia score (≥ 2)

4.464 (0.902–22.222)

0.067

Septic shock

10.526 (1.376–76.923)

0.023

Pulmonary infection

6.289 (1.351–29.412)

0.019

Appropriate therapy started within 24 h

0.288 (0.066–1.255)

0.097

CAZ-AVI-containing regimen

0.068 (0.007–0.651)

0.020

  1. OR, odds ratio; CI, confidence interval; CAZ-AVI, ceftazidime-avibactam
Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us